Further analysis revealed that EA treatment can reverse the changes in several KEGG pathways caused by obesity: PPAR signaling pathway, glycolysis/gluconeogenesis, calcium signaling pathway, and glucagon signaling pathway (Figures 3(c) and 3(f)). This evidence concerns the gene GCG and obesity disorder.